(26 days)
Not Found
No
The description focuses on the material properties and physical characteristics of a collagen membrane, with no mention of AI or ML technologies for analysis, processing, or any other function.
Yes
The device is indicated as a dural substitute for the repair of dura mater, which is a therapeutic intervention.
No
The device is indicated as a "dural substitute for the repair of dura mater," which describes a therapeutic or reconstructive function, not a diagnostic one. It replaces or repairs tissue rather than identifying or characterizing a disease or condition.
No
The device description clearly states it is a "membrane matrices engineered from highly purified type I collagen derived from bovine Achilles tendon," indicating a physical, hardware-based medical device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is "as dural substitutes for the repair of dura mater." This describes a surgical implant used directly in the body to replace damaged tissue.
- Device Description: The description details a physical membrane made of collagen, designed to be implanted.
- Lack of Diagnostic Function: There is no mention of the device being used to test samples (like blood, urine, or tissue) outside of the body to diagnose a condition. IVDs are used for diagnostic purposes, not for direct therapeutic or reconstructive procedures within the body.
The device is a surgical implant, not a diagnostic tool.
N/A
Intended Use / Indications for Use
The Collagen Dura Substitute Membranes are indicated for use as a dural substitute for the repair of dura mater.
DuraMatrix™ Collagen Dura Substitute Membranes are indicated as dural substitutes for the repair of dura mater.
Product codes
GXQ
Device Description
The Collagen Dura Substitute Membrane are white, nonfriable, conformable, resorbable, membrane matrices engineered from highly purified type I collagen derived from bovine Achilles tendon. The devices have thicknesses similar to that of native dura. They are flexible and conform to the contours of the defect site. The Collagen Dura Substitute Membranes are supplied sterile, non-pyrogenic, in various sizes, and for single use only.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
dura mater
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The results of a large-scale animal study and clinical study of the equivalent product support the effectiveness of using a membrane material as a dura substitute in the repair of dura mater. The characteristics of the modified Collagen Dura Substitute Membranes meet the design requirements for an effective dura substitute.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 882.5910 Dura substitute.
(a)
Identification. A dura substitute is a sheet or material that is used to repair the dura mater (the membrane surrounding the brain).(b)
Classification. Class II (performance standards).
0
K061487 Page 1/2
510(k) Summary of Safety and Effectiveness
| Applicant Name and Address: | Collagen Matrix, Inc.
509 Commerce Street
Franklin Lakes, New Jersey 07417 | JUN 26 2006 |
|-----------------------------|--------------------------------------------------------------------------------------------------------------------------|-------------|
| Contact Person: | Peggy Hansen, RAC
Director, Clinical, Regulatory, and Quality Assurance
Tel: (201) 405-1477
Fax: (201) 405-1355 | |
| Date of Summary: | May 30, 2006 | |
| Device Common Name: | Collagen Dura Substitute Membranes | |
| Device Trade Name: | DuraMatrix™ Collagen Dura Substitute Membranes | |
| Device Classification Name: | Dura substitute
Class II
882.5910
GXQ | |
| Predicate Device(s): | DuraMatrix™ Collagen Dura Substitute Membrane,
K040888 | |
Description of the Device
The Collagen Dura Substitute Membrane are white, nonfriable, conformable, resorbable, membrane matrices engineered from highly purified type I collagen derived from bovine Achilles tendon. The devices have thicknesses similar to that of native dura. They are flexible and conform to the contours of the defect site. The Collagen Dura Substitute Membranes are supplied sterile, non-pyrogenic, in various sizes, and for single use only.
Intended Use
The Collagen Dura Substitute Membranes are indicated for use as a dural substitute for the repair of dura mater.
Summary/Comparison of Technical Characteristics
Collagen Dura Substitute Membranes and their predicate have similar technological characteristics. In particular, the Collagen Dura Substitute Membrane and its predicates are similar with respect to intended use, material, form, sizes, thickness, physical integrity, pore structure and conformability.
1
Safety
Collagen Dura Substitute Membrane equivalent has been evaluated by a number of tests to assess its safety/biocompatibility. The device passed all applicable FDA Blue Book Memorandum G95-1and ISO 10993-1 testing for the biological evaluation of medical devices.
Effectiveness
The results of a large-scale animal study and clinical study of the equivalent product support the effectiveness of using a membrane material as a dura substitute in the repair of dura mater. The characteristics of the modified Collagen Dura Substitute Membranes meet the design requirements for an effective dura substitute.
Conclusion
The results of the in vitro product characterization studies show that the device modifications of the Collagen Dura Substitute Membrane are safe and substantially equivalent to the original device.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH AND HUMAN SERVICES USA" around the perimeter. Inside the circle is a stylized graphic of three human profiles facing to the right, with flowing lines representing hair or clothing.
JUN 26 2006
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Collagen Matrix, Inc. c/o Peggy Hansen, RAC Director, Clinical, Regulatory, and Quality Assurance 509 Commerce Street Franklin Lakes, New Jersey 07417
Re: K061487
Trade/Device Name: DuraMatrix™ Collagen Dura substitute Membranes Regulation Number: 21 CFR 882.5910 Regulation Name: Dura Substitute Regulatory Class: Class II Product Code: GXQ Dated: June 7, 2006 Received: June 8, 2006
Dear Ms. Hansen:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the idecations for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the 1 clity. general controls pro sions of the Act include requirements for annual registration, isting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA). it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 898. In addition. In the way publish further announcements concerning your device in the Federal Register.
Please be advised that FDA`s issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. Younny of comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the lectronic product radiation control provisions (Sections 531-542 of the Actil 11 CFR 100-0.000.
3
Page 2 - Peggy Hansen
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely vours
Oabara Bneem
Mark Melkerson Director Division of General, Restorative And Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
510(k) Number (if known): | K061487 |
---|---|
--------------------------- | --------- |
Device Name: DuraMatrix™ Collagen Dura Substitute Membranes
Indications for Use:
DuraMatrix™ Collagen Dura Substitute Membranes are indicated as dural substitutes for the repair of dura mater.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Cladia, Philip, Joseph
(Doris, Sister)
Div neral, Restorative. and Neurological Devices
Page 1 of _1
510(k) Number